JP3789632B2 - Liquid preparation containing sporic lactic acid bacteria - Google Patents
Liquid preparation containing sporic lactic acid bacteria Download PDFInfo
- Publication number
- JP3789632B2 JP3789632B2 JP03834598A JP3834598A JP3789632B2 JP 3789632 B2 JP3789632 B2 JP 3789632B2 JP 03834598 A JP03834598 A JP 03834598A JP 3834598 A JP3834598 A JP 3834598A JP 3789632 B2 JP3789632 B2 JP 3789632B2
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- acid bacteria
- spore
- liquid preparation
- spores
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Non-Alcoholic Beverages (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は有胞子乳酸菌を含有する液剤に関する。
【0002】
【従来の技術及び発明が解決しようとする課題】
最近、“体質改善をねらった健康指向の食品”、特に腸の環境改善効果を目指した商品への要望が高まってきている。例えば、ある種の乳酸菌又はビフィズス菌は継続的飲用すると腸内菌叢を改善するので、それにより健康を増進する研究が活発化している。しかし、乳酸菌は一般に寿命が短く、特に乾燥条件下ではその生存率は極めて低い。また健康増進効果を得るには、胃液及び胆汁酸による影響をのがれて腸管に達する必要性がある。そこで多くのメーカーは、耐酸性乳酸菌の利用、腸溶性カプセルを用いた導入方法を採用しはじめている。
一方、有胞子乳酸菌〔バチルス コアグランス(Bacillus coagulans) 〕は、一般的な乳酸菌と異なり、一定の条件下で乾燥にも熱や酸にも非常に強く、腸内で発芽して活発に増殖する特性を有し、各種食品へ応用されている。
しかし、有胞子乳酸菌は、胞子が発芽せずに成熟胞子のままでいてこそ、耐熱性等に優れるものであり、一旦発芽し発芽胞子(発芽胞子は更に栄養細胞へと変化する)となると、耐熱性、耐薬品性等が失われる。
そこで、有胞子乳酸菌の安定化(胞子を発芽させずに成熟胞子のまま維持すること)について種々検討された結果、粉末の状態では極めて安定で、1年以上にわたり一定の菌数を保持することが知られている。しかし、水系で安定に保持する方法は未だ提案されてない。
即ち、有胞子乳酸菌は生理食塩水や糖水溶液に保存しても、経時的に死滅菌数が増加し、各種飲料等への応用ができない。
更に、有胞子乳酸菌の胞子を液剤に配合する場合、胞子の安定性の低さが食品や医薬品の商品設計上大きな問題点であった。例えば、低pHの条件下では、胞子発芽後、栄養細胞に発育し、その後死滅する問題があった。
【0003】
【課題を解決するための手段】
本発明者らは上記課題を解決すべく鋭意検討した結果、低pH条件下で液剤の浸透圧を制御することにより、液剤中で胞子の発芽を抑制し、胞子の形態を安定に保持する技術を見出し、本発明を完成した。
即ち、本発明は、
下記1)〜4)を満たし、50℃で2週間保存した後に、胞子の残存率が12.2%以上であることを特徴とする有胞子乳酸菌を含有する液剤である。
1)バチルス コアグランス(Bacillus coagulans) の胞子を 1.0×103 個/ml以上を含むこと
2)浸透圧が0.699〜1.5 Osmol /kgの範囲に入ること
3)pHが2.7 〜4.5 の範囲にあること
4) 還元麦芽糖水飴及び/又はショ糖を含むこと
【0004】
【発明の実施の形態】
以下、本発明について詳細に説明する。
胞子の発芽は、胞子表面から水が侵入した際に、溶解しているカルシウムイオン、マグネシウムイオンなどの2価金属イオンにより誘発される(細菌の解剖:水島昭二、三浦謹一郎著、講談社サイエンティフィック出版、1979年)。本発明者らは、胞子の周りの浸透圧を上げる、すなわち胞子の表面にかかる圧力を上げることにより、外からの水の進入を少なくし発芽を抑制する方法を見出した。浸透圧とは、厳密には希薄溶液で取り扱うことのできる定義である。溶質濃度が高い液剤の場合、一見、浸透圧を適用することが困難であると考えられるが、本発明者らは浸透圧と有胞子乳酸菌の胞子残存率の間には正の相関関係があることを知見した。浸透圧は、水に溶解する分子(溶質)の数に比例することから、溶質の量が多いと浸透圧は高い関係が生じる。
液剤の浸透圧を上げるには、塩類、糖類などの水可溶性成分を添加すれば良い。塩類としては、ナトリウム、カリウム、マグネシウム、カルシウムなどの金属を含む塩類、乳性ミネラル、有機酸塩類などが挙げられる。糖類としては、グルコースなどの単糖、ショ糖などの二糖、オリゴ糖、多糖類、糖アルコール類が挙げられる。また、蛋白質、アミノ酸、ペプチドなども用い得る。
上記オリゴ糖としては、フラクトオリゴ糖、イソマルトオリゴ糖、キシロオリゴ糖、乳果オリゴ糖などを用い得る。
糖アルコールとしては、エリスリトール、キシリトール、マルチトール、ソルビトールなどが挙げられる。糖アルコールは、バチルス・コアグランスにより資化されず、保存時の発芽抑制効果があり、好適である。
【0005】
本発明において、浸透圧は、フォーゲル社(独)の氷点降下法を利用した浸透圧計(機種名 OM802)で測定した。
本発明においては、液剤の浸透圧は0.3 〜1.5 Osmol /kgの範囲に入ることが必要であり、好ましくは0.4 〜1.0 Osmol /kgの範囲である。0.3 Osmol /kg以上であれば、胞子の安定性が向上する。しかし、1.5 Osmol /kgを越えると液剤としての味のバランスを失い、商品の価値が失われる。
【0006】
また、本発明では、液剤のpHは2.7 〜4.5 の範囲が必要であり、好ましくは3.2 〜4.0 、特に好ましくは3.3 〜3.8 の範囲である。pHが上記範囲内にあれば、胞子の発芽が比較的起こりにくく、また高温殺菌を要しないので、風味の良い液剤が得られる。
【0007】
本発明の液剤は、液状の食品および医薬品に適用できる。例えば、食品では乳酸菌飲料、清涼飲料、ゼリー状飲料、スープ類、プリンやゼリーなどのデザート類、ポーション類、果汁、野菜ジュース、アイスクリーム、乳化食品などが挙げられる。医薬品では、一般的にドリンク剤として表現される液剤、シロップ剤、ドライシロップ剤、乳剤、エキス剤、煎剤などに用いられる。但し、液状の形態であればこれに記載される限りではない。
【0008】
上記食品および医薬品の流通は、冷凍、チルド、常温の3つのタイプに限られ、飲料の保存はこれらの温度に対応することが望まれる。本品は、有胞子乳酸菌を含むため、凍結すると死滅する恐れがある。このため、保存はチルドおよび常温が好ましい。しかし、チルドでの流通および保存の場合は、輸送や保存に関るランニングコストが多大となることから、工業的有用性を考慮して、常温での保存が好ましい。
【0009】
本発明において、例えば1本1リットルの液剤を想定した場合、液剤中に 1.0×103 個/mlの濃度になるようにBacillus Coagulanse の胞子を配合すると、正味胞子数は 1.0×106 個/本となる。この量を含むことにより、腸の環境改善効果が得られる。好ましくは、 1.0×104 〜 1.0×108 個/ml、特に好ましくは 1.0×105 〜 1.0×107 個/mlの濃度で配合する。
本発明の液剤は、50℃で2週間保存した後の胞子残存率が1%以上である。
本発明において、胞子残存率は以下のように測定した。
飲料のベース配合を85℃に30分間さらし、殺菌した。これに、予め85℃で10分間加熱処理した有胞子乳酸菌胞子懸濁液を無菌状態下で 1.0×103 個/ml以上になるように添加した。これを50℃の恒温室で保存し、2週間後の残存率を測定した。即ち、2週間後に0.5ml ずつサンプリングし、4.5ml の滅菌した50mMリン酸バッファー(pH7)で希釈後、80℃で30分加熱後冷却し、BCP寒天培地(日水製薬(株))に塗沫し、50℃で2日培養後、生じたコロニー数より胞子の残存率を求めた。
50℃で2週間の保存は加速試験であり、常温で保存した場合の約1年4ヶ月に相当する。常温で6ヶ月間保存した後の胞子残存率は、1%以上であることが好ましく、特に10%以上、より好ましくは50%以上である。
【0010】
本発明において、有胞子乳酸菌は市販品だけでなく、自然界より新たに単離されたもの、または市販品より選抜育種または変異育種したものも使用できる。
【0011】
本発明の液剤には、保存中に起こる成分の酸化劣化を抑制する目的で、抗酸化剤を添加できる。中でも、ビタミンE、β−カロチンなどの脂溶性の抗酸化剤は、胞子安定化合効果を有し好適である。
【0012】
また、本発明の液剤には、風味向上から醗酵乳の添加が望ましい。醗酵乳は、脱脂粉乳、全脂粉乳、生乳、乳蛋白質の中の1種及び2種以上を含む原料をラクトバチルス属および/又はビフィズス属を用いて醗酵させて調製する。醗酵乳は、殺菌醗酵乳、生菌を含む醗酵乳、メイラード反応生成物を含む醗酵乳(褐変醗酵乳)等のタイプがあるが、中でも、殺菌醗酵乳の使用が好ましい。また、乳清成分を原料にした醗酵液や醗酵エキスも用い得る。
【0013】
本発明の液剤には、その他、香料、ヨーグルトフレーバー、果実系フレーバー、安定化剤、ペクチンなどの多糖類なども添加できる。
【0014】
【実施例】
以下、実施例により本発明を更に具体的に説明する。
実施例1〜7、比較例1〜2
表1に示す処方の液剤に、ラクリス(三共(株)製、登録商標)粉末より単離した有胞子乳酸菌を表1に示す量添加した。そのpH(乳酸、クエン酸で調整)と浸透圧を表1に併せて示す。
この液剤について、前記方法により、50℃で2週間保存した後の胞子の残存率を測定した結果も表1に併せて示す。
実施例8、比較例3〜4
表2に示す処方の液剤を用いた以外は前記実施例と同様に試験を行った。結果を表2に示す。
【0015】
【表1】
【0016】
【表2】
[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a liquid preparation containing sporic lactic acid bacteria.
[0002]
[Prior art and problems to be solved by the invention]
Recently, there has been an increasing demand for “health-oriented foods aimed at improving the constitution”, in particular, products aimed at improving the intestinal environment. For example, certain types of lactic acid bacteria or bifidobacteria improve gut microbiota when continuously ingested, thereby accelerating research to promote health. However, lactic acid bacteria generally have a short life, and their survival rate is extremely low, especially under dry conditions. In addition, in order to obtain a health promoting effect, it is necessary to reach the intestinal tract by removing the influence of gastric juice and bile acids. Therefore, many manufacturers are beginning to adopt acid-resistant lactic acid bacteria and introduction methods using enteric capsules.
On the other hand, sporic lactic acid bacteria (Bacillus coagulans), unlike general lactic acid bacteria, are extremely resistant to drying, heat and acid under certain conditions, and germinate and proliferate actively in the intestine. It is applied to various foods.
However, the spore lactic acid bacteria are excellent in heat resistance and the like if the spores remain as mature spores without germination, and once germinate and germinate spores (the germinated spores are further transformed into vegetative cells), Heat resistance, chemical resistance, etc. are lost.
Therefore, as a result of various investigations on the stabilization of spore lactic acid bacteria (maintaining mature spores without germinating spores), they are extremely stable in a powder state and should maintain a certain number of bacteria for more than one year. It has been known. However, no method has been proposed for stably maintaining in an aqueous system.
That is, even if the sporic lactic acid bacteria are stored in physiological saline or an aqueous sugar solution, the number of death sterilization increases with time, and it cannot be applied to various beverages.
Furthermore, when the spores of spore lactic acid bacteria are added to the solution, the low stability of the spores has been a major problem in the product design of foods and pharmaceuticals. For example, under low pH conditions, there has been a problem that after spore germination, vegetative cells grow and then die.
[0003]
[Means for Solving the Problems]
As a result of intensive studies to solve the above problems, the present inventors have controlled the osmotic pressure of the liquid under low pH conditions, thereby suppressing spore germination in the liquid and maintaining the spore morphology stably. The present invention has been completed.
That is, the present invention
A liquid preparation containing spore lactic acid bacteria characterized by satisfying the following 1) to 4) and storing at 50 ° C. for 2 weeks and having a remaining spore ratio of 12.2 % or more.
1) Contain at least 1.0 × 10 3 spores / ml of Bacillus coagulans spores
2) Osmotic pressure should be in the range of 0.699 to 1.5 Osmol / kg.
3) The pH is in the range of 2.7 to 4.5.
4) Containing reduced maltose starch syrup and / or sucrose
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, the present invention will be described in detail.
Spore germination is induced by divalent metal ions such as dissolved calcium ions and magnesium ions when water enters from the spore surface (bacterial anatomy: written by Shoji Mizushima and Shinichiro Miura, Kodansha Scientific) Publishing, 1979). The present inventors have found a method of suppressing germination by increasing the osmotic pressure around the spores, that is, by increasing the pressure applied to the surface of the spores, thereby reducing the entry of water from the outside. Strictly speaking, osmotic pressure is a definition that can be handled with dilute solutions. In the case of a liquid preparation with a high solute concentration, it seems that it is difficult to apply osmotic pressure at first glance, but the present inventors have a positive correlation between the osmotic pressure and the spore residual rate of spore lactic acid bacteria. I found out. Since the osmotic pressure is proportional to the number of molecules (solutes) dissolved in water, there is a high relationship between the osmotic pressure and the amount of solute.
In order to increase the osmotic pressure of the solution, water-soluble components such as salts and saccharides may be added. Examples of the salts include salts containing metals such as sodium, potassium, magnesium, and calcium, milk minerals, and organic acid salts. Examples of the saccharide include monosaccharides such as glucose, disaccharides such as sucrose, oligosaccharides, polysaccharides, and sugar alcohols. Proteins, amino acids, peptides, and the like can also be used.
As the oligosaccharide, fructooligosaccharide, isomaltooligosaccharide, xylo-oligosaccharide, dairy oligosaccharide and the like can be used.
Examples of the sugar alcohol include erythritol, xylitol, maltitol, sorbitol and the like. Sugar alcohol is not assimilated by Bacillus coagulans and has a germination inhibitory effect during storage, which is preferable.
[0005]
In the present invention, the osmotic pressure was measured with an osmometer (model name OM802) using the freezing point depression method of Vogel (Germany).
In the present invention, the osmotic pressure of the solution needs to be in the range of 0.3 to 1.5 Osmol / kg, and preferably in the range of 0.4 to 1.0 Osmol / kg. If it is 0.3 Osmol / kg or more, the stability of the spore is improved. However, if it exceeds 1.5 Osmol / kg, the balance of the taste as a liquid is lost and the value of the product is lost.
[0006]
In the present invention, the pH of the liquid preparation needs to be in the range of 2.7 to 4.5, preferably 3.2 to 4.0, particularly preferably 3.3 to 3.8. If the pH is within the above range, spore germination is relatively unlikely and high-temperature sterilization is not required, so that a savory liquid agent can be obtained.
[0007]
The liquid preparation of the present invention can be applied to liquid foods and pharmaceuticals. Examples of foods include lactic acid bacteria beverages, soft drinks, jelly-like beverages, soups, desserts such as pudding and jelly, potions, fruit juices, vegetable juices, ice creams, and emulsified foods. In pharmaceuticals, it is used for liquids, syrups, dry syrups, emulsions, extracts, decoctions and the like that are generally expressed as drinks. However, the liquid form is not limited to this.
[0008]
Distribution of the foods and pharmaceuticals is limited to three types: frozen, chilled, and room temperature, and it is desired that beverages be stored at these temperatures. This product contains sporic lactic acid bacteria and may die if frozen. For this reason, storage is preferably chilled and normal temperature. However, in the case of distribution and storage in a chilled state, running costs related to transportation and storage become large, so that storage at room temperature is preferable in consideration of industrial usefulness.
[0009]
In the present invention, for example, assuming a solution of 1 liter per bottle, when Bacillus Coagulanse spores are mixed in the solution to a concentration of 1.0 × 10 3 cells / ml, the net spore count is 1.0 × 10 6 cells / ml. Become a book. By including this amount, the effect of improving the intestinal environment can be obtained. Preferably, it is blended at a concentration of 1.0 × 10 4 to 1.0 × 10 8 cells / ml, particularly preferably 1.0 × 10 5 to 1.0 × 10 7 cells / ml.
The liquid preparation of the present invention has a spore residual rate of 1% or more after storage at 50 ° C. for 2 weeks.
In the present invention, the spore survival rate was measured as follows.
The beverage base formulation was exposed to 85 ° C for 30 minutes and sterilized. To this, a spore suspension of spore lactic acid bacteria previously heated at 85 ° C. for 10 minutes was added at 1.0 × 10 3 cells / ml or more under aseptic conditions. This was stored in a thermostatic chamber at 50 ° C., and the residual rate after 2 weeks was measured. In other words, 0.5 ml each was sampled after 2 weeks, diluted with 4.5 ml of sterilized 50 mM phosphate buffer (pH 7), heated at 80 ° C. for 30 minutes, cooled, and applied to BCP agar medium (Nissui Pharmaceutical Co., Ltd.) After spraying and culturing at 50 ° C. for 2 days, the spore survival rate was determined from the number of colonies formed.
Storage at 50 ° C for 2 weeks is an accelerated test and corresponds to about 1 year and 4 months when stored at room temperature. The spore residual rate after storage at room temperature for 6 months is preferably 1% or more, particularly 10% or more, more preferably 50% or more.
[0010]
In the present invention, the sporic lactic acid bacteria are not limited to commercially available products, but those newly isolated from nature, or those that have been selected or mutated from commercially available products can be used.
[0011]
An antioxidant can be added to the liquid preparation of the present invention for the purpose of suppressing oxidative degradation of components that occur during storage. Among these, fat-soluble antioxidants such as vitamin E and β-carotene are preferable because they have a spore stabilization effect.
[0012]
Moreover, addition of fermented milk is desirable for the liquid agent of this invention from flavor improvement. Fermented milk is prepared by fermenting a raw material containing one or more of skim milk powder, whole milk powder, raw milk and milk protein using Lactobacillus and / or Bifidobacterium. Fermented milk includes types such as sterilized fermented milk, fermented milk containing live bacteria, and fermented milk (brown fermented milk) containing Maillard reaction products, among which the use of sterilized fermented milk is preferable. Moreover, the fermentation liquid and fermentation extract which used the whey component as a raw material can also be used.
[0013]
In addition, flavoring agents, yogurt flavors, fruit flavors, stabilizers, polysaccharides such as pectin and the like can be added to the liquid preparation of the present invention.
[0014]
【Example】
Hereinafter, the present invention will be described more specifically with reference to examples.
Examples 1-7, Comparative Examples 1-2
To the solution having the formulation shown in Table 1, sporic lactic acid bacteria isolated from Lacris (registered trademark, manufactured by Sankyo Co., Ltd.) powder were added in the amounts shown in Table 1. The pH (adjusted with lactic acid and citric acid) and osmotic pressure are also shown in Table 1.
Table 1 also shows the results of measuring the residual ratio of spores after storage at 50 ° C. for 2 weeks for this solution.
Example 8, Comparative Examples 3-4
The test was conducted in the same manner as in the above example except that the liquid formulation having the formulation shown in Table 2 was used. The results are shown in Table 2.
[0015]
[Table 1]
[0016]
[Table 2]
Claims (4)
1)バチルス コアグランス(Bacillus coagulans) の胞子を 1.0×103 個/ml以上を含むこと
2)浸透圧が0.699〜1.5 Osmol /kgの範囲に入ること
3)pHが2.7 〜4.5 の範囲にあること
4) 還元麦芽糖水飴及び/又はショ糖を含むこと A liquid preparation containing a spore lactic acid bacterium characterized by satisfying the following 1) to 4) and storing for 2 weeks at 50 ° C. and having a spore residual rate of 12.2 % or more.
1) Contain at least 1.0 × 10 3 spores / ml of Bacillus coagulans spores
2) Osmotic pressure should be in the range of 0.699 to 1.5 Osmol / kg.
3) The pH is in the range of 2.7 to 4.5.
4) Containing reduced maltose starch syrup and / or sucrose
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03834598A JP3789632B2 (en) | 1998-02-20 | 1998-02-20 | Liquid preparation containing sporic lactic acid bacteria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03834598A JP3789632B2 (en) | 1998-02-20 | 1998-02-20 | Liquid preparation containing sporic lactic acid bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11225721A JPH11225721A (en) | 1999-08-24 |
| JP3789632B2 true JP3789632B2 (en) | 2006-06-28 |
Family
ID=12522708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP03834598A Expired - Fee Related JP3789632B2 (en) | 1998-02-20 | 1998-02-20 | Liquid preparation containing sporic lactic acid bacteria |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3789632B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019103441A (en) * | 2017-12-12 | 2019-06-27 | 三菱ケミカルフーズ株式会社 | Acidic beverage containing lactobacillus sporogenes and method of producing the same |
| CN110537573A (en) * | 2018-05-28 | 2019-12-06 | 可口可乐公司 | A kind of production method of the normal-temperature acid drink containing spore-type Bacillus coagulans |
-
1998
- 1998-02-20 JP JP03834598A patent/JP3789632B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11225721A (en) | 1999-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4791429B2 (en) | Fermented milk and lactic acid bacteria beverages containing oligosaccharides and plant lactic acid bacteria | |
| CA2753083C (en) | Symbiotic maple product compositions and methods | |
| CN1802101B (en) | Use of isomalt (mixture of 1,6GPS and 1,1 GPM) as prebiotic for the production of medicaments for the treatment of intestinal diseases and other uses | |
| KR100632718B1 (en) | Improved Microbial Formulations | |
| WO2008116355A1 (en) | A method for preparing ambient-stable direct-acidified milk beverage with high counts of viable lactic acid bacteria | |
| JP4778490B2 (en) | Fermented milk containing indigestible oligosaccharides and lactic acid bacteria | |
| Baglio | Chemistry and technology of yoghurt fermentation | |
| CN102448332A (en) | Trehalulose-containing composition, its preparation and use | |
| US20150010674A1 (en) | Probiotic or symbiotic gelled products and method for the production thereof | |
| JP7763029B2 (en) | Fermented composition | |
| JP3381010B2 (en) | Fermented product containing propolis extract, production method and use thereof | |
| Soliman et al. | Characteristics of fermented camel’s milk fortified with kiwi or avocado fruits | |
| CN112293492A (en) | Application of polysaccharide dietary fiber as stabilizer, fermented milk and lactobacillus beverage | |
| JP4296133B2 (en) | Chilled beverage and method for producing the same | |
| TR201818839T4 (en) | Ready-to-Drink Milk Beverages with Enhanced Tissue / Mouth Feeling with Controlled Protein Caking and Method for Their Preparation. | |
| JP3789632B2 (en) | Liquid preparation containing sporic lactic acid bacteria | |
| TW201906537A (en) | Non-carbonated liquid food and drink containing microbial cells, and method for improving dispersibility of precipitates or aggregates of microbial powders in foods and drinks | |
| Janipour et al. | Effects of partial replacement of sugar with fig syrup on the survival of Bacillus coagulans and the physicochemical properties of probiotic ice cream | |
| CN106550991A (en) | The method for maintaining lactobacillus beverage shelf life inner tissue state stability | |
| JP2009089627A (en) | Fermented food containing cellooligosaccharide and plant lactic acid bacteria | |
| Nauth | Yogurt | |
| CN114246213A (en) | A method for preparing beverage containing heat sensitive active substance | |
| JPH05168432A (en) | Material for oligosaccharide-containing food and drink, food and drink containing the same and production of the same material | |
| CN111937963A (en) | Flavored fermented milk compositions and methods of making and using same | |
| JP6849890B2 (en) | Composition for preserving deoxyribonucleic acid and its production method, method for preserving deoxyribonucleic acid, lactic acid bacterium product and method for its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040907 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040907 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20051226 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20060117 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060228 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060328 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060329 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090407 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100407 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110407 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120407 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130407 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130407 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140407 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |